Suvecaltamide

N/A

Report date: 2024/06/21 17:15:06
NMEFirst In Class

Base Information

Drug NameSuvecaltamide
Drug Alias NameMK-8998CX-8998JZP-385
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated T-type calcium channel modulators
TargetsVoltage-gated T-type calcium channel
Therapy Area/IndicationsSchizophreniaTremorEssential Tremor +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandGermany +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesJazz Pharmaceuticals Plc
Inactive CompaniesMerck Sharp & Dohme LLC
Active IndicationsTremorEssential TremorParkinson Disease
Inactive IndicationsSchizophreniaEpilepsy

Other Information

ATC CodeN/A
Related LinksN/A